Humana Inc. (HUM) Shares Bought by Sei Investments Co.
Sei Investments Co. raised its position in shares of Humana Inc. (NYSE:HUM) by 22.7% during the second quarter, Holdings Channel reports. The institutional investor owned 26,416 shares of the insurance provider’s stock after buying an additional 4,884 shares during the period. Sei Investments Co.’s holdings in Humana were worth $6,354,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also modified their holdings of HUM. Daiwa Securities Group Inc. increased its position in shares of Humana by 4.7% in the second quarter. Daiwa Securities Group Inc. now owns 4,450 shares of the insurance provider’s stock worth $1,071,000 after buying an additional 200 shares in the last quarter. CAPROCK Group Inc. purchased a new position in shares of Humana during the second quarter worth approximately $213,000. Tokio Marine Asset Management Co. Ltd. increased its position in shares of Humana by 20.2% in the second quarter. Tokio Marine Asset Management Co. Ltd. now owns 8,703 shares of the insurance provider’s stock worth $2,094,000 after buying an additional 1,464 shares during the period. Rothschild Asset Management Inc. increased its position in shares of Humana by 27.4% in the second quarter. Rothschild Asset Management Inc. now owns 5,112 shares of the insurance provider’s stock worth $1,230,000 after buying an additional 1,100 shares during the period. Finally, Eagle Global Advisors LLC purchased a new position in shares of Humana during the second quarter worth approximately $211,000. Institutional investors and hedge funds own 99.13% of the company’s stock.
Humana Inc. (HUM) opened at 246.83 on Wednesday. The firm has a market cap of $35.67 billion, a PE ratio of 20.31 and a beta of 0.91. Humana Inc. has a 52-week low of $163.50 and a 52-week high of $255.27. The company’s 50 day moving average price is $240.31 and its 200 day moving average price is $223.89.
Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, topping analysts’ consensus estimates of $3.08 by $0.41. Humana had a return on equity of 15.85% and a net margin of 3.37%. The business had revenue of $13.53 billion during the quarter, compared to analysts’ expectations of $13.61 billion. During the same quarter last year, the company posted $2.30 earnings per share. Analysts predict that Humana Inc. will post $11.55 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: This news story was first reported by Watch List News and is owned by of Watch List News. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.watchlistnews.com/humana-inc-hum-shares-bought-by-sei-investments-co/1493283.html.
A number of research analysts have commented on the company. BidaskClub upgraded Humana from a “sell” rating to a “hold” rating in a research note on Thursday, August 10th. UBS AG restated a “neutral” rating and issued a $250.00 target price (up previously from $237.00) on shares of Humana in a research note on Wednesday, August 9th. Deutsche Bank AG boosted their target price on Humana from $234.00 to $243.00 and gave the company a “hold” rating in a research note on Monday, August 7th. Jefferies Group LLC restated a “hold” rating and issued a $257.00 target price on shares of Humana in a research note on Friday, August 4th. Finally, Cantor Fitzgerald restated a “neutral” rating and issued a $223.00 target price (up previously from $200.00) on shares of Humana in a research note on Thursday, August 3rd. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have issued a buy rating to the stock. Humana presently has an average rating of “Buy” and an average target price of $243.65.
In related news, CEO Bruce D. Broussard sold 12,000 shares of Humana stock in a transaction dated Friday, August 11th. The stock was sold at an average price of $251.88, for a total transaction of $3,022,560.00. Following the completion of the transaction, the chief executive officer now owns 80,086 shares in the company, valued at $20,172,061.68. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP M Todoroff Christopher sold 22,935 shares of Humana stock in a transaction dated Thursday, August 10th. The stock was sold at an average price of $252.52, for a total value of $5,791,546.20. Following the transaction, the vice president now owns 24,001 shares of the company’s stock, valued at approximately $6,060,732.52. The disclosure for this sale can be found here. Insiders have sold 41,406 shares of company stock valued at $10,355,086 in the last quarter. 0.80% of the stock is currently owned by corporate insiders.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.